Home › Research › Biomarkers
Influence of cognitive impairment and race on plasma p-Tau217 in two diverse cohorts
Nayyar A, Li ML, Sotelo V, Su G, Hwang I, Kaluzova M, Jomartin M, Migut M et al.. Alzheimer's & dementia : the journal of the Alzheimer's Association, 2025-02-01
Topic: Brain proteins, microglia and lab models
Plain-language summary
Introduction Factors influencing plasma Alzheimer's disease (AD) biomarkers remain incompletely understood. Here we evaluated Fujirebio plasma p-Tau 217 in two diverse cohorts among whom 91% underwent cerebrospinal fluid (CSF) analysis. Methods Non-Hispanic White (NHW, n = 113), Black/African American (B/AA, n = 66), and Chinese American (ChA, n = 38) participants recruited from two universities were included. We examined if plasma p-Tau 217 correlated with CSF and clinical factors, differed between racial groups, and associated with novel CSF proteins. Results CSF p-Tau 181 strongly correlated with CSF p-Tau 217 (R 2 = 0.912) which moderately correlated with plasma p-Tau 217 (R 2 = 0.694). Plasma p-Tau 217 levels were higher with greater cognitive impairment but lower in B/AA than NHW participants even after adjusting for CSF p-Tau 181 . This resulted in greater positive predictive value for NHW than B/AA participants, and could be mediated by complement or lysosomal pathways. Discussion Severity of cognitive impairment and race both influence plasma p-Tau 217 levels beyond race-associated differences in CSF p-Tau 181 . Highlights Cognitive impairment associates with plasma p-Tau 217 independent of CSF biomarkers. Black/African Americans had lower plasma p-Tau 217 than non-Hispanic White Americans. CSF p-Tau 181 could not explain lower plasma p-Tau 217 in Black/African Americans. Plasma p-Tau 217 difference results in more false positive cases according to race. Novel CSF processes were associated with race-related plasma p-Tau 217 difference.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Nayyar, A., Li, M. L., Sotelo, V., Su, G., Hwang, I., Kaluzova, M., et al. (2025). Influence of cognitive impairment and race on plasma p-Tau217 in two diverse cohorts. Alzheimer's & dementia : the journal of the Alzheimer's Association. https://doi.org/10.1002/alz.14585
Vancouver
Nayyar A, Li ML, Sotelo V, Su G, Hwang I, Kaluzova M, et al. Influence of cognitive impairment and race on plasma p-Tau217 in two diverse cohorts. Alzheimer's & dementia : the journal of the Alzheimer's Association. 2025. doi:10.1002/alz.14585. PMID: 39988568.
BibTeX
@article{nayyar2025-39988568,
author = {Nayyar, A. and Li, M. L. and Sotelo, V. and Su, G. and Hwang, I. and Kaluzova, M. and Jomartin, M. and Migut, M. and others},
title = {{Influence of cognitive impairment and race on plasma p-Tau217 in two diverse cohorts}},
journal = {Alzheimer's \& dementia : the journal of the Alzheimer's Association},
year = {2025},
doi = {10.1002/alz.14585},
pmid = {39988568},
url = {https://doi.org/10.1002/alz.14585}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.
Key findings
- We examined if plasma p-Tau 217 correlated with CSF and clinical factors, differed between racial groups, and associated with novel CSF proteins.
- Results CSF p-Tau 181 strongly correlated with CSF p-Tau 217 (R 2 = 0.912) which moderately correlated with plasma p-Tau 217 (R 2 = 0.694).
- Plasma p-Tau 217 difference results in more false positive cases according to race.
- Novel CSF processes were associated with race-related plasma p-Tau 217 difference.
New to this subject? Start with our plain-English guide: Blood tests & biomarkers →
Study details
- Participants113
- Evidence strengthLow
How this study scored 57/100
Published in a leading specialty journal. Scored zero for study design, effect reported and randomized / blinded because the record does not state it. We have no data on journal's citation record, times cited, citations per year, impact for its field and year, cited by studies here, still being cited, senior author's track record, institution's track record and multicenter collaboration, so those were left out: it earned 33 of the 58 points we could judge it on, which is 57 out of 100.
| Component | Points | Why |
|---|---|---|
| Journal tier | 9 / 10 | Tier 2 — leading specialty journal (Alzheimer's & dementia : the journal of the Alzheimer's Association) |
| Journal's citation record | — / 4 | No journal record from OpenAlex — left out of this score |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 4 / 5 | 2025 — within 3 year(s) of the newest study here |
| Sample size | 2 / 4 | 113 participants |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 3 / 3 | Studied in people (participant count stated) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | — / 7 | No citation count (not found in OpenAlex) — left out of this score |
| Citations per year | — / 5 | No citation count or no year — left out of this score |
| Impact for its field and year | — / 6 | No field-weighted citation impact (OpenAlex has none yet) — left out of this score |
| Cited by studies here | — / 6 | Not yet checked against this library's citation graph — left out of this score |
| Still being cited | — / 4 | No yearly citation counts — left out of this score |
| Senior author's track record | — / 4 | Senior author's record not available — left out of this score |
| Institution's track record | — / 3 | No institution listed in OpenAlex — left out of this score |
| Multicenter collaboration | — / 3 | Institutions not listed — left out of this score |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 39988568) |
| Free to read | 2 / 2 | Free to read |
| Points | 33 / 58 | Scored on 11 of 20 parts. We have no data for the rest, so they are left out: 33 of the 58 points we could judge it on is 57 out of 100. |
| Total | 57 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
Free copy unknown: no free-copy check has an answer for this record yet. That does not mean it is paywalled.
Related
Studies in the library that share something with this one. The line above each title says what.